Peptides / Cagrilintide / Australia
Cagrilintide in Australia
Legal status, what it is, and the listed suppliers in Australia that list it.
Legal status in Australia
Not an approved medicine. Not listed by name in the Poisons Standard (June 2026).
As understood at 2026-09-22. Verify with the TGA.
What Cagrilintide is
Cagrilintide is a long-acting synthetic analogue of amylin, a 37-amino-acid hormone released alongside insulin that slows stomach emptying and signals fullness. Developed by Novo Nordisk, it is mostly studied in combination with semaglutide under the name CagriSema. It is an investigational drug and not yet licensed anywhere.
Listed suppliers in Australia
3 of the 10 suppliers we list in Australia list Cagrilintide. Listed, not endorsed: each row is the supplier’s own stated terms.
Au Peptide Labs
Australia
For laboratory research use only. Not for human consumption.
Aussie Peptides
Australia
Research use only. Statements have not been evaluated by the TGA. We do not ship internationally at this time.
Australian Peptide Site
Australia
Intended for laboratory and scientific research use only.